A Basis for Reduced Chemical Library Inhibition of Firefly Luciferase Obtained from Directed Evolution

被引:59
作者
Auld, Douglas S. [1 ]
Zhang, Ya-Qin [1 ]
Southall, Noel T. [1 ]
Rai, Ganesha [1 ]
Landsman, Marc [1 ]
MacLure, Jennifer [1 ]
Langevin, Daniel [1 ]
Thomas, Craig J. [1 ]
Austin, Christopher P. [1 ]
Inglese, James [1 ]
机构
[1] NIH, Chem Genom Ctr, Bethesda, MD 20892 USA
关键词
THROUGHPUT SCREENING ASSAYS; PROTEIN-KINASE; BIOLUMINESCENT ASSAYS; IDENTIFICATION; TRANSCREENER(TM); FLUORESCENCE; ACTIVATION; DISCOVERY; DRUGABILITY; MECHANISM;
D O I
10.1021/jm8014525
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We measured the "druggability" of the ATP-dependent luciferase derived from the firefly Photuris pennsylvanica that was optimized using directed evolution (Ultra-Glo, Promega). Quantitative high-throughput screening (qHTS) was used to determine IC(50)S of 198899 samples against a formulation of Ultra-Glo luciferase (Kinase-Glo). We found that only 0.1 % of the Kinase-Glo inhibitors showed an IC(50) < 10 mu M compared to 0.9% found from a previous qHTS against the firefly luciferase from Photinus pyralis (lucPpy). Further, the maximum affinity identified in the lucPpy qHTS was 50 nM, while for Kinase-Glo this value increased to 600 nM. Compounds with interactions stretching outside the luciferin binding pocket were largely lost with Ultra-Glo luciferase. Therefore, Ultra-Glo luciferase will show less compound interference when used as an ATP sensor compared to lucPpy. This study demonstrates the power of large-scale quantitative analysis of structure-activity relationships (> 100K compounds) in addressing important questions such as a target's druggability.
引用
收藏
页码:1450 / 1458
页数:9
相关论文
共 46 条
  • [1] A specific mechanism for nonspecific activation in reporter-gene assays
    Auld, Douglas S.
    Thorne, Natasha
    Nguyen, Dac-Trung
    Inglese, James
    [J]. ACS CHEMICAL BIOLOGY, 2008, 3 (08) : 463 - 470
  • [2] Characterization of chemical libraries for luciferase inhibitory activity
    Auld, Douglas S.
    Southall, Noel T.
    Jadhav, Ajit
    Johnson, Ronald L.
    Diller, David J.
    Simeonov, Anton
    Austin, Christopher P.
    Inglese, James
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) : 2372 - 2386
  • [3] A high throughput luminescent assay for glycogen synthase kinase-3β inhibitors
    Baki, Andrea
    Bielik, Attila
    Molnar, Laszlo
    Szendrei, Gyorgyi
    Keseru, Gyorgy M.
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (01) : 75 - 83
  • [4] Cali JJ, 2008, EXPERT OPIN DRUG MET, V4, P103, DOI [10.1517/17425255.4.1.103, 10.1517/17425255.4.1.103 ]
  • [5] Luminogenic cytochrome P450 assays
    Cali, James J.
    Ma, Dongping
    Sobol, Mary
    Simpson, Daniel J.
    Frackman, Susan
    Good, Troy I.
    Daily, William J.
    Liu, David
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 629 - 645
  • [6] Structure-based maximal affinity model predicts small-molecule druggability
    Cheng, Alan C.
    Coleman, Ryan G.
    Smyth, Kathleen T.
    Cao, Qing
    Soulard, Patricia
    Caffrey, Daniel R.
    Salzberg, Anna C.
    Huang, Enoch S.
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (01) : 71 - 75
  • [7] Nanoliter dispensing for uHTS using pin tools
    Cleveland, PH
    Koutz, PJ
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2005, 3 (02) : 213 - 225
  • [8] Comley J., 2006, DRUG DISCOVERY WORLD, V7, P27
  • [9] The minimum significant ratio: A statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies
    Eastwood, BJ
    Farmen, MW
    Iversen, PW
    Craft, TJ
    Smallwood, JK
    Garbison, KE
    Delapp, NW
    Smith, GF
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (03) : 253 - 261
  • [10] A structural biology view of target drugability
    Egner, Ursula
    Hillig, Roman C.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (04) : 391 - 401